The use of chemotherapy to facilitate surgical resection in pleomorphic xanthoastrocytoma: experience in a single case

Childs Nerv Syst. 2001 Sep;17(9):563-6. doi: 10.1007/s003810100451.

Abstract

The use of noncytotoxic chemotherapy as an adjuvant treatment to permit resection of a pleomorphic xanthoastrocytoma (PXA) is described. A 6-year-old girl with a large right occipito-temporo-parietal lesion presented with signs and symptoms of raised intracranial pressure. An initial attempt at resection was halted because of excessive blood loss, and tumour embolisation was not feasible as no suitable vascular pedicle was identified. Two cycles of vincristine and carboplatin were given, and these decreased the vascularity of the tumour allowing subsequent complete macroscopic resection 9 weeks later. The use of chemotherapy to decrease the vascularity of the tumour by way of its antiangiogenic effects is discussed.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Astrocytoma / blood supply
  • Astrocytoma / drug therapy*
  • Astrocytoma / surgery
  • Brain Neoplasms / blood supply
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / surgery
  • Carboplatin / adverse effects
  • Carboplatin / therapeutic use
  • Child
  • Combined Modality Therapy
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Neoadjuvant Therapy*
  • Neovascularization, Pathologic / diagnosis
  • Neovascularization, Pathologic / drug therapy
  • Tomography, X-Ray Computed
  • Vincristine / administration & dosage
  • Vincristine / adverse effects

Substances

  • Vincristine
  • Carboplatin